Maynard Um
-
-
-
-
-
-
-
Evaxion reports $7.5 million revenue from MSD licensing deal for 2025
-
-
-
-
-
-
-
Sidoti Events, LLC's Year-End Virtual Investor Conference
-
-
-
-
-
-
-
Evaxion raises $7.2 million, extends cash runway to second half of 2027
-
-
-
-
-
-
-
Evaxion Biotech (EVAX) expands R&D pipeline with new vaccine program targeting Group A Streptococcus
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Evaxion Biotech (EVAX)
-
-
-
-
-
-
-
Evaxion Biotech (EVAX) announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1
-
-
-
-
-
-
-
Evaxion Biotech (EVAX) launches improved AI-Immunology platform for vaccine antigen prediction
-
418,478 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

